Halozyme Therapeutics, Inc. (HALO)
67.12
-2.09
(-3.02%)
USD |
NASDAQ |
May 15, 16:00
67.14
+0.02
(+0.04%)
Pre-Market: 20:00
Halozyme Therapeutics Price : 67.12 for May 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 436.95 |
| Agenus, Inc. | 3.58 |
| Inovio Pharmaceuticals, Inc. | 1.30 |
| Curis, Inc. | 0.4902 |
| LadRx Corp. | 0.107 |
Price Related Metrics
| PE Ratio | 24.14 |
| PS Ratio | 5.418 |
| Price to Book Value | 36.25 |
| Price to Free Cash Flow | 12.24 |
| Earnings Yield | 4.14% |
| Market Cap | 7.961B |
| Operating PE Ratio | 9.511 |
| Normalized PE Ratio | 13.76 |